Home › Funds › GREAT POINT PARTNERS LLC › GMAB

GREAT POINT PARTNERS LLC position in GMAB

GENMAB A/S · Health Care

GREAT POINT PARTNERS LLC reported holding 525,000 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 4.69% of its reported portfolio and ranking #8 among its reported holdings. GREAT POINT PARTNERS LLC first reported this position in Q3 2026.

Latest position (Q3 2026)525.00K sh
Reported value held$18.73M
Portfolio Weight4.69%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's GMAB position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in GMAB in Q3 2026 at 525,000 shares (US$18.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 525.00K $18.73M New

About GMAB and 13F data

GMAB (GENMAB A/S) is a Health Care company. 35 other funds we track also report a position in GMAB — the largest reported positions include Darwin Global Management, Ltd. (US$638.6M), Paradigm Biocapital Advisors LP (US$504.3M), Orbis Allan Gray Ltd (US$377.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMAB

All GMAB fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held GMAB?

GREAT POINT PARTNERS LLC has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is GREAT POINT PARTNERS LLC's current position in GMAB?

As of Q3 2026, GREAT POINT PARTNERS LLC holds 525.00K shares of GMAB (GENMAB A/S), valued at $18.73M, representing 4.69% of its reported portfolio and ranking #8.

Has GREAT POINT PARTNERS LLC been buying or selling GMAB?

In the latest 13F filing (Q3 2026), GREAT POINT PARTNERS LLC newly opened its position in GMAB.

Which other funds hold GMAB?

Other major institutional holders of GMAB include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.